CYTK - Latest News
Cytokinetics, Incorporated (CYTK), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $9.61B. Beta to the broader market is 0.38.
The article list below shows the most recent CYTK headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent CYTK Headlines
Cytokinetics to Host Annual Symposium on Contemporary Landscapes in Muscle Biology (CLIMB)
globenewswire.com - May 14, 2026
Third Annual Muscle Biology-Focused Research Symposium Highlighting Recent Innovations in the Field SOUTH SAN FRANCISCO, Calif. , May 14, 2026 (GLOBE
Cytokinetics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
globenewswire.com - May 12, 2026
SOUTH SAN FRANCISCO, Calif. , May 12, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company m
Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026
globenewswire.com - May 11, 2026
SOUTH SAN FRANCISCO, Calif. , May 11, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the presentation of new data
Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $805 Million
globenewswire.com - May 8, 2026
SOUTH SAN FRANCISCO, Calif. , May 08, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the closing of an underwritte
Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock
globenewswire.com - May 6, 2026
SOUTH SAN FRANCISCO, Calif. , May 06, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the pricing of an underwritte
How News Affects CYTK Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track CYTK's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked CYTK news questions
- What is the latest CYTK news headline?
- The most recent CYTK headline (May 14, 2026) is "Cytokinetics to Host Annual Symposium on Contemporary Landscapes in Muscle Biology (CLIMB)". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the CYTK news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What CYTK news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual CYTK options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.